Eylea Cost: $1,444.50 a Dose at Medicare's Own Price
Medicare allows $1,444.50 for the drug in one Eylea injection and $2,327.22 for Eylea HD, plus $114.23 for the injection itself. On Original Medicare your share is $311.75 or $488.29 per shot, every time, with no yearly cap. Here is the arithmetic from CMS's published October 2026 payment file, the biosimilar that costs more than the brand, and the two ways this bill goes wrong.
- Eylea bills under J0178 at $722.251 per 1 mg, and the standard dose is 2 mg, so a correct claim shows exactly 2 units. Eylea HD bills under J0177 at $290.902 per mg for an 8 mg dose, so 8 units.
- A year of Eylea in one eye is roughly $1,870 to $2,490 of your own money in Part B coinsurance. Eylea HD on a stretched schedule lands in the same place, around $2,440, so fewer visits does not mean a smaller bill.
- The aflibercept biosimilar Opuviz is currently allowed $763.376 per mg, about 6% more than brand Eylea. A switch to it raises your coinsurance.
What One Eylea Injection Is Allowed
Part B pays for Eylea off a payment limit that CMS republishes every quarter (average sales price plus 6%). These are the limits in force October 1 through December 31, 2026, in a retina practice's own office.
| Line item | Eylea, 2 mg | Eylea HD, 8 mg |
|---|---|---|
| Billing code | J0178 | J0177 |
| Payment limit per 1 mg | $722.251 | $290.902 |
| Units on a correct claim | 2 | 8 |
| Drug allowed | $1,444.50 | $2,327.22 |
| Injection, CPT 67028 (office) | $114.23 | $114.23 |
| Total allowed, one eye | $1,558.73 | $2,441.45 |
| Your 20% on Original Medicare | $311.75 | $488.29 |
Source: CMS October 2026 Medicare Part B payment limit file (2Q26 ASP data) and the 2026 physician fee schedule (CPT 67028, 3.42 non-facility RVUs at the $33.4009 conversion factor). A hospital outpatient department bills differently: see the site of care section below.
Want to know what your Eylea (aflibercept) eye injection should cost you?
Costs vary substantially by procedure, location, facility, and insurance. Get a personalized estimate based on your situation.
Already have a bill? Send it to CareRoute and we will work to reduce it. 64% of cases reduced.
The Yearly Cost, and Why Eylea HD Does Not Save You Money
Eylea's label is 2 mg monthly for the first three months, then every 8 weeks, which works out to roughly 6 to 8 injections in the first year per eye. Eylea HD is 8 mg monthly for three months, then every 8 to 16 weeks, and real-world data put its first-year count around 5. Fewer visits, bigger dose, similar total:
| One eye, first year | Allowed total | Your 20% |
|---|---|---|
| Eylea, 6 injections | $9,352.39 | $1,870.48 |
| Eylea, 8 injections | $12,469.86 | $2,493.97 |
| Eylea HD, 5 injections | $12,207.23 | $2,441.45 |
| Eylea HD, 6 injections | $14,648.68 | $2,929.74 |
Original Medicare never caps this
Part B pays 80% after a $283 annual deductible in 2026 and there is no out-of-pocket maximum. Your 20% runs for as long as you need injections, and both eyes doubles it. A Medigap policy, a Medicare Advantage plan, retiree coverage, or Medicaid is the only thing that stops it.
If you were recently diagnosed and are still inside a guaranteed-issue Medigap window, that window matters more than anything else on this page. In most states Medigap is medically underwritten afterwards, and a wet AMD diagnosis makes it hard to buy later.
The Aflibercept Biosimilar Costs More Than Eylea
Several aflibercept biosimilars have been approved. The one carrying a Medicare payment limit in the current file is Opuviz (aflibercept-ayyh, Q5147), and it is allowed $763.376 per mg against brand Eylea's $722.251. For the same 2 mg dose that is $1,526.75 instead of $1,444.50, and your 20% goes from $288.90 to $305.35 on the drug.
That is the opposite of what a biosimilar is supposed to do, and it is a quirk of how Part B pricing works: the limit tracks actual market selling price, recalculated quarterly, not list price. Brand Eylea's own limit has been drifting down all year as competition arrived:
| Quarter, 2026 | J0178 per mg (Eylea) | J0177 per mg (Eylea HD) |
|---|---|---|
| January | $763.901 | $306.985 |
| April | $731.885 | $301.177 |
| July | $743.605 | $298.683 |
| October (current) | $722.251 | $290.902 |
Practical version: ask your retina office which aflibercept product they are billing. Between products in the same class it is a small clinical question and a real money question, and the office is the only place that knows the answer.
The Two Ways an Eylea Bill Goes Wrong
1. The unit count
J0178 is priced per 1 mg and the dose is 2 mg, so a correct claim for one eye shows 2 units, not 1 and not 4. J0177 (Eylea HD) shows 8. If the claim doubles the units, the charge moves by about $1,444 and nothing about it looks obviously wrong. Check the unit column on the statement or the explanation of benefits against this page, and confirm CPT 67028 appears once per eye with an RT or LT modifier (modifier 50 if both eyes were injected at the same visit). A one-eye visit billed as two is the other common version of the same error.
2. A step therapy denial you were never told about
Medicare Advantage plans are allowed to apply step therapy to Part B drugs, and several of them list aflibercept products in those programs, meaning they want bevacizumab or another agent tried first. Commercial plans do the same. If the prior authorization was not obtained or the step was not documented, the claim is denied and the full charge falls to you. That is appealable with your retina specialist's records, and it is worth appealing at this dollar amount. See our denial appeal guide.
Where You Get the Shot Changes the Bill
The $1,444.50 of drug is the same anywhere. The rest is not. In the retina practice's office, the injection is allowed $114.23 and that is the entire non-drug charge. In a hospital outpatient department the physician's portion drops to $75.49 and the hospital adds its own facility fee, which is normally the bigger of the two. If a routine injection is being scheduled at a hospital clinic, ask whether the practice can do it in the office instead.
How to Pay Less
Ask whether bevacizumab fits your case
Compounded bevacizumab costs the clinic $50 to $70 a dose instead of $1,444.50, and National Eye Institute trials found it worked about as well as ranibizumab for wet AMD. Many specialists start there and move to Eylea if the response is not good enough. It is a medical decision, but asking the question is worth about $1,700 a year to you. See Avastin eye injection cost.
Commercial insurance: the manufacturer copay program
Regeneron runs EYLEA4U, which includes copay support for commercially insured patients and can cover most of your coinsurance. Your retina clinic normally enrolls you. Watch for a copay accumulator or maximizer clause in your plan, which can keep that help from counting toward your deductible.
Medicare: a charity fund, because the copay card is not allowed
Federal rules bar manufacturer copay assistance for Medicare patients. The route that works is an independent foundation with an open macular degeneration or retinal disease fund: the PAN Foundation, HealthWell Foundation, and Good Days. They close when the money runs out, so apply the day you find one open. Our medication assistance checker routes by coverage type.
Already have the bill
A recurring four-figure drug charge is worth checking properly. CareRoute Bill Defense reviews the coding and units, pursues the denial if there is one, and negotiates the balance. Free to submit, and you only pay if we reduce it.
Frequently Asked Questions
How much does Eylea cost per injection?
Medicare's payment limit for October through December 2026 is $722.251 per 1 mg of aflibercept (code J0178), and the standard dose is 2 mg, so the drug is allowed $1,444.50. Adding $114.23 for the injection procedure in a doctor's office brings one treatment to $1,558.73. On Original Medicare you owe 20%, which is $311.75 per injection per eye. Eylea HD (8 mg, code J0177) is allowed $2,327.22 for the drug and $2,441.45 in total, so your share is $488.29.
Does Medicare cover Eylea?
Yes, under Part B rather than a Part D drug plan, because a clinician injects it. Part B pays 80% of the allowed amount after the 2026 annual deductible of $283, and you owe the other 20% with no annual out-of-pocket maximum. A Medigap policy, a Medicare Advantage plan, retiree coverage, or Medicaid is what limits your exposure. Medicare Advantage plans may also require prior authorization or step therapy before they will pay for Eylea.
How many units of J0178 should my bill show?
Two. J0178 is priced per 1 mg and the standard Eylea dose is 2 mg per eye, so a correct claim for one eye shows 2 units. Eylea HD uses code J0177 at 8 units for an 8 mg dose. The injection procedure, CPT 67028, should appear once per eye with an RT or LT modifier, or modifier 50 if both eyes were treated at the same visit. A doubled unit count moves the charge by roughly $1,444 and is the single most valuable thing to check on the statement.
Is the Eylea biosimilar cheaper?
Not right now. Opuviz (aflibercept-ayyh, code Q5147) carries a Medicare payment limit of $763.376 per mg in the October 2026 file, which is about 6% higher than brand Eylea at $722.251. For a 2 mg dose that is $1,526.75 instead of $1,444.50, so your 20% is higher too. Part B limits track actual market selling prices and change every quarter, so this can flip. Ask your retina office which product they bill.
What does a year of Eylea cost?
Eylea is given monthly for three months and then about every 8 weeks, so 6 to 8 injections in the first year per eye. At Medicare's allowed amounts that is $9,352 to $12,470 total, and your 20% is $1,870 to $2,494 for one eye, double for two. Eylea HD at a stretched schedule of about 5 injections comes to $12,207 allowed and $2,441 to you, so the longer interval mostly buys fewer office visits rather than a lower bill.
Can I get help paying for Eylea?
If you have commercial insurance, Regeneron's EYLEA4U program includes copay support that can cover most of your share. If you have Medicare, manufacturer copay help is not legally available to you, and the route that works is an independent charity foundation with an open fund for macular degeneration or retinal disease, such as the PAN Foundation, HealthWell Foundation, or Good Days. If you are uninsured, ask the clinic about manufacturer patient assistance, and ask separately whether compounded bevacizumab is clinically appropriate, since it costs a small fraction of Eylea.
Related Guides
Sources
- CMS, October 2026 Medicare Part B Payment Limit File (ASP pricing file), effective October 1 to December 31, 2026, based on 2Q26 ASP data: J0178 $722.251 per 1 mg, J0177 $290.902 per 1 mg, Q5147 $763.376 per 1 mg. January, April, and July 2026 files for the quarterly trend.
- CMS, 2026 National Physician Fee Schedule Relative Value File (October release): CPT 67028, 3.42 non-facility and 2.26 facility total RVUs, conversion factor $33.4009.
- FDA prescribing information for Eylea (aflibercept) 2 mg and Eylea HD (aflibercept) 8 mg for dosing and schedule.
- CMS, 2026 Medicare Parts A and B premiums and deductibles (Part B deductible $283).
- National Eye Institute Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) on bevacizumab versus ranibizumab.
Medicare payment limits are republished quarterly; these are the October to December 2026 figures. Commercial plans pay their own negotiated rates, usually higher. Which drug is right for you is a decision for you and your retina specialist. This is cost information, not medical advice. Last updated November 12, 2026.